Aberdeen Group’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-193,921
| Closed | -$14.7M | – | 954 |
|
|
2026
Q1 | $14.7M | Buy |
193,921
+2,054
| +1% | +$154K | 0.02% | 502 |
|
|
2025
Q4 | $14.3M | Sell |
191,867
-2,090
| -1% | -$153K | 0.02% | 527 |
|
|
2025
Q3 | $13.1M | Sell |
193,957
-51,040
| -21% | -$3.39M | 0.02% | 554 |
|
|
2025
Q2 | $16M | Buy |
244,997
+6,589
| +3% | +$395K | 0.03% | 479 |
|
|
2025
Q1 | $14.7M | Sell |
238,408
-132,130
| -36% | -$8.75M | 0.03% | 470 |
|
|
2024
Q4 | $26.7M | Sell |
370,538
-13,484
| -4% | -$1.05M | 0.05% | 312 |
|
|
2024
Q3 | $31.1M | Buy |
384,022
+18,830
| +5% | +$1.51M | 0.06% | 293 |
|
|
2024
Q2 | $27.1M | Sell |
365,192
-10,095
| -3% | -$757K | 0.05% | 310 |
|
|
2024
Q1 | $29.3M | Buy |
375,287
+17,016
| +5% | +$1.27M | 0.06% | 314 |
|
|
2023
Q4 | $25.6M | Buy |
358,271
+68,920
| +24% | +$4.8M | 0.06% | 329 |
|
|
2023
Q3 | $20.1M | Buy |
289,351
+18,070
| +7% | +$1.37M | 0.05% | 321 |
|
|
2023
Q2 | $22M | Sell |
271,281
-8,909
| -3% | -$728K | 0.05% | 327 |
|
|
2023
Q1 | $22.6M | Buy |
280,190
+20,051
| +8% | +$1.61M | 0.06% | 319 |
|
|
2022
Q4 | $19.5M | Buy |
260,139
+21,879
| +9% | +$1.56M | 0.05% | 342 |
|
|
2022
Q3 | $15.4M | Buy |
238,260
+99,528
| +72% | +$6.89M | 0.05% | 359 |
|
|
2022
Q2 | $9.72M | Buy |
138,732
+13,218
| +11% | +$981K | 0.03% | 431 |
|
|
2022
Q1 | $9.74M | Buy |
125,514
+30,423
| +32% | +$2.19M | 0.02% | 450 |
|
|
2021
Q4 | $7.28M | Sell |
95,091
-19,958
| -17% | -$1.47M | 0.02% | 560 |
|
|
2021
Q3 | $8.56M | Buy |
115,049
+2,735
| +2% | +$205K | 0.02% | 526 |
|
|
2021
Q2 | $7.49M | Sell |
112,314
-3,792
| -3% | -$254K | 0.02% | 566 |
|
|
2021
Q1 | $8.64M | Buy |
116,106
+14,115
| +14% | +$1.07M | 0.02% | 529 |
|
|
2020
Q4 | $7.43M | Buy |
101,991
+3,946
| +4% | +$279K | 0.02% | 518 |
|
|
2020
Q3 | $6.52M | Sell |
98,045
-8,252
| -8% | -$522K | 0.02% | 507 |
|
|
2020
Q2 | $6.06M | Sell |
106,297
-8,701
| -8% | -$427K | 0.02% | 508 |
|
|
2020
Q1 | $4.04M | Buy |
114,998
+11,882
| +12% | +$566K | 0.01% | 556 |
|
|
2019
Q4 | $5.38M | Sell |
103,116
-7,868
| -7% | -$392K | 0.01% | 583 |
|
|
2019
Q3 | $5.6M | Sell |
110,984
-97,416
| -47% | -$4.79M | 0.01% | 568 |
|
|
2019
Q2 | $10M | Sell |
208,400
-381,567
| -65% | -$17.6M | 0.02% | 504 |
|
|
2019
Q1 | $28.6M | Sell |
589,967
-50,620
| -8% | -$2.28M | 0.06% | 284 |
|
|
2018
Q4 | $26.1M | Sell |
640,587
-59,826
| -9% | -$2.45M | 0.06% | 281 |
|
|
2018
Q3 | $28.7M | Sell |
700,413
-15,935
| -2% | -$644K | 0.05% | 320 |
|
|
2018
Q2 | $28.5M | Buy |
716,348
+426,286
| +147% | +$16.4M | 0.05% | 316 |
|
|
2018
Q1 | $10.8M | Buy |
290,062
+136,440
| +89% | +$5.51M | 0.02% | 435 |
|
|
2017
Q4 | $6.57M | Sell |
153,622
-125,934
| -45% | -$5.02M | 0.01% | 512 |
|
|
2017
Q3 | $10.3M | Buy |
+279,556
| New | +$11.3M | 0.02% | 446 |
|
Other funds holding HOLX
Aberdeen Group's HOLX Position: Q2 2026 in Review
Aberdeen Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 193,921 shares — an estimated $14.7M sold.
Aberdeen Group first reported a position in HOLX in Q3 2017 and held it in 35 quarters. The position peaked at $31.1M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Aberdeen Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Aberdeen Group sold 193,921 Hologic shares in Q2 2026, an estimated $14.7M.
- Aberdeen Group first reported a position in Hologic in Q3 2017 and held it in 35 quarters.
- Aberdeen Group's Hologic position peaked at $31.1M in Q3 2024.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.